"Mongkol Pongsuchart,Takahiro Kuchimaru,Sakiko Yonezawa,Diem Thi Phuong Tran,Nguyen The Kha,Ngoc Thi Hong Hoang,Tetsuya Kadonosono,Shinae Kondoh","Novel lymphoid enhancer-binding factor 1-cytoglobin axis promotes extravasation of osteosarcoma cells into the lungs",,"Cancer Science",,"Vol. 109","No. 9","pp. 2746-2756",2018,Sept.
"伊藤 雄大,門之園 哲哉,ThiHongNgoc Hoang,口丸 高弘,近藤 科江","HIF活性化細胞を標的とした新規融合タンパク質製剤の物性評価","第39回日本分子生物学会年会",,,,,,2016,Dec.
"PONGSUCHART M,米澤 早紀子,Hoang ThiHongNgoc,口丸 高弘,門之園 哲哉,近藤 科江","Identification of genes regulating osteosarcoma extravasation in lung metastasis","第39回日本分子生物学会年会",,,,,,2016,Dec.
"TRAN T.PHUONG DIEM,PONGSUCHART M,米澤 早紀子,Hoang ThiHongNgoc,口丸 高弘,門之園 哲哉,近藤 科江","Analysis of Wnt signaling involvement in lung metastasis by using murine osteosarcoma cell lines","第75回日本癌学会学術総会",,,,,,2016,Oct.
"伊藤 雄大,門之園 哲哉,ThiHongNgoc Hoang,口丸 高弘,近藤 科江","低酸素がんを標的とした融合タンパク質製剤の物性評価","第75回日本癌学会学術総会",,,,,,2016,Oct.
"米澤 早紀子,Mongkol Pongsuchart,Diem Tran,Hoang Thi Hong Ngoc,口丸 高弘,門之園 哲哉,近藤 科江","骨肉腫の肺転移における血管外浸潤過程を制御する分子機構の解析","第75回日本癌学会学術総会",,,,,,2016,Oct.
"HoangThiHongNgoc","HIF標的プロドラッグTOP3と化学治療薬の併用治療によるすい臓がんの治療効果の検証",,,,,,,2016,Sept.
"Thi Hong Ngoc Hoang","Evaluation of the efficacy of HIF-targeting prodrug TOP3 in combination with chemotherapeutic drugs for pancreatic cancer treatment",,,,,,,2016,Sept.
"Thi Hong Ngoc Hoang","Evaluation of the efficacy of HIF-targeting prodrug TOP3 in combination with chemotherapeutic drugs for pancreatic cancer treatment",,,,,,,2016,Sept.
"近藤 科江,門之園 哲哉,Hoang Thi Hong Ngoc,伊藤雄大,口丸高弘","HIFが活性化したがんを標的にした融合タンパク質製剤を用いた難治がん治療法の開発","第20回日本がん分子標的治療学会学術集会",,,,,,2016,May
"PONGSUCHART M,Nguyen KhaThe,米澤 早紀子,Hoang ThiHongNgoc,口丸 高弘,門之園 哲哉,近藤 科江","Identification of responsible genes for osteosarcoma extravasation in lung metastasis by using in vivo image-guided system","第11回日本分子イメージング学会総会・学術集会",,,,,,2016,May
"近藤 科江,門之園 哲哉,Hoang Thi Hong Ngoc,伊藤雄大,口丸高弘","低酸素誘導転写因子HIFが活性化したがんを標的にした融合タンパク質製剤を用いた","日本がん分子標的治療学会",,,,,,2016,May
"Hoang ThiHongNgoc,門之園 哲哉,口丸 高弘,近藤 科江","Enhanced antitumor effect of TOP3 and Gemcitabine combination therapy for pancreatic cancer treatment","第13回がんとハイポキシア研究会",,,,,,2015,June
"Hoang ThiHongNgoc,門之園 哲哉,口丸 高弘,近藤 科江","Enhanced antitumor effects of TOP-3 and TS-1 combination therapy for pancreatic cancer treatment","第12回がんとハイポキシア研究会",,,,,,2014,Nov.